Abstract
Purpose
The purpose of this study is to investigate whether progesterone (P4) levels on the day of frozen-thawed embryo transfer (FET) to a hormonally prepared endometrium correlate with pregnancy outcomes.
Methods
This is a large retrospective cohort analysis comprising of N = 2010 FETs. In these cycles, P4 levels on the day of transfer were assessed in relation to pregnancy outcomes. A threshold of 10 ng/mL was used to simulate currently accepted levels for physiological corpus luteal function. Biochemical pregnancy, clinical pregnancy, and live birth rates were compared between those with P4 levels above and below this threshold. Analyses using transfer day P4 thresholds of 5 ng/mL and 20 ng/mL were then completed to see if these could create further prognostic power.
Results
When comparing FET outcomes in relation to P4 levels < 10 ng/mL and ≥ 10 ng/mL, we observed no differences in biochemical pregnancy rates (39.53% vs. 40.98%, p = 0.52), clinical pregnancy rates (20.82 vs. 22.78, p = 0.30), and live birth rates (14.25 vs. 16.21 p = 0.23). In patients whose P4 met the threshold of 20 ng/mL, there was similarly no statistically significant improvement in pregnancy outcomes. While there was no difference for biochemical or clinical pregnancy rates, a statistically significant improvement in live birth rates was observed for those with a transfer day P4 level ≥ 5 ng/mL.
Conclusions
We demonstrated that P4 levels at or above 10 ng/mL on the day of FET do not confer a statistically significant improvement in pregnancy outcomes. P4 below 5 ng/mg was associated with lower live birth rates suggesting that there is a threshold below which it is difficult to salvage FET cycles.
Similar content being viewed by others
References
Cedrin-Durnerin I, et al. Serum progesterone concentration and live birth rate in frozen-thawed embryo transfers with hormonally prepared endometrium. Reprod BioMed Online. 2019;38(3):472–80.
van der Linden M, et al. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015;7.
Taraborrelli S. Physiology, production and action of progesterone. Acta Obstet Gynecol Scand. 2015;94:8–16.
Miles RA, Paulson RJ, Lobo RA, Press MF, Dahmoush L, Sauer MV. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril. 1994;62(3):485–90.
Paulson RJ, Collins MG, Yankov VI. Progesterone pharmacokinetics and pharmacodynamics with 3 dosages and 2 regimens of an effervescent micronized progesterone vaginal insert. J Clin Endocrinol Metab. 2014;99(11):4241–9.
De Ziegler D, et al. The first uterine pass effect. Ann N Y Acad Sci. 1997;828:291–9.
Racca A, Santos-Ribeiro S, de Munck N, Mackens S, Drakopoulos P, Camus M, et al. Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: is there a deleterious effect on embryo quality? Hum Reprod. 2018;33(5):860–8.
Esteves SC, et al. Association between progesterone elevation on the day of human chronic gonadotropin trigger and pregnancy outcomes after fresh embryo transfer in in vitro fertilization/intracytoplasmic sperm injection cycles. Front Endocrinol (Lausanne). 2018;9:201.
Ibrahim Y, et al. Elevated progesterone and its impact on birth weight after fresh embryo transfers. J Assist Reprod Genet. 2017;34(6):759–64.
Lawrenz B, Fatemi HM. Effect of progesterone elevation in follicular phase of IVF-cycles on the endometrial receptivity. Reprod BioMed Online. 2017;34(4):422–8.
Yovich JL, Conceicao JL, Stanger JD, Hinchliffe PM, Keane KN. Mid-luteal serum progesterone concentrations govern implantation rates for cryopreserved embryo transfers conducted under hormone replacement. Reprod BioMed Online. 2015;31(2):180–91.
Solomon HF, Sneeringer RM, Penzias AS. Prediction of pregnancy outcome by serum progesterone level after assisted reproductive technology. Fertil and Steril. 2008;90:Supp 231.
Arce JC, Balen A, Platteau P, Pettersson G, Andersen AN. Mid-luteal progesterone concentrations are associated with live birth rates during ovulation induction. Reprod BioMed Online. 2011;22(5):449–56.
Blakemore JK, Kofinas JD, McCulloh D, Grifo J. Serum progesterone trend after day of transfer predicts live birth in fresh IVF cycles. J Assist Reprod Genet. 2017;34(3):339–43.
Labarta E, et al. Low serum progesterone on the day of embryo transfer is associated with a diminished ongoing pregnancy rate in oocyte donation cycles after artificial endometrial preparation: a prospective study. Hum Reprod. 2017;32(12):2437–42.
Brady PC, Kaser DJ, Ginsburg ES, Ashby RK, Missmer SA, Correia KF, et al. Serum progesterone concentration on day of embryo transfer in donor oocyte cycles. J Assist Reprod Genet. 2014;31(5):569–75.
Tihomirova T, et al. Measurement of serum progesterone levels on the day of embryo transfer is a useful tool in prediction of successful pregnancy. Annuaire de l'Afrique du Nord. 2018;103:53–9.
Kofinas JD, Blakemore J, McCulloh D, Grifo J. Serum progesterone levels greater than 20 ng/dl on day of embryo transfer are associated with lower live birth and higher pregnancy loss rates. J Assist Reprod Genet. 2015;32(9):1395–9.
Sifer C, et al. Outcome of embryo vitrification compared to slow freezing process at early cleavage stages. Report of the first French birth. Gynecol Obstet Fertil. 2012;40(3):158–61.
Gardner, D. and W. Schoolcraft, In vitro culture of human blastocyst, in Towards Reproductive Certainty: Fertility and Genetics Beyond 1999, J. R and M. D, Editors., Parthenon Publishing Carnforth: UK. 1999 p. 378–388.
Hull MG, Savage PE, Bromham DR, Ismail AA, Morris AF. The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived form treated and untreated conception cycles. Fertil Steril. 1982;37(3):355–60.
Jordan J, et al. Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertil Steril. 1994;62(1):54–62.
Kumar P, Magon N. Hormones in pregnancy. Niger Med J. 2012;53(4):179–83.
Spencer TE, Bazer FW. Biology of progesterone action during pregnancy recognition and maintenance of pregnancy. Front Biosci. 2002;7:d1879–98.
Bayard F, Louvet JP, Monrozies M, Boulard A, Pontonnier G. Endometrial progesterone concentrations during the menstrual cycle. J Clin Endocrinol Metab. 1975;41(2):412–4.
Carson RL, Ganjam VK, Hudson RS, McLeod C, Kwapien R. Plasma and endometrial progesterone content following exogenous progesterone administration in mares. Theriogenology. 1983;19(2):235–41.
Cicinelli E, et al. Direct transport of progesterone from vagina to uterus. Obstet Gynecol. 2000;95(3):403–6.
Nahoul K, Dehennin L, Jondet M, Roger M. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas. 1993;16(3):185–202.
Archer DF, et al. Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone. Am J Obstet Gynecol. 1995;173(2):471–7 discussion 477–8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Volovsky, M., Pakes, C., Rozen, G. et al. Do serum progesterone levels on day of embryo transfer influence pregnancy outcomes in artificial frozen-thaw cycles?. J Assist Reprod Genet 37, 1129–1135 (2020). https://doi.org/10.1007/s10815-020-01713-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-020-01713-w